Researchers find new genetic target for sickle cell disease therapy

Researchers have identified a gene that directly affects the production of a form of haemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease and thalassemia. The discovery could lead to breakthrough therapies for sickle cell disease and thalassemia, which could potentially eliminate the devastating and life-threatening complications of these diseases, such as severe pain, damage to the eyes and other organs, infections, and stroke...

Read the whole article on

More from